Pfizer, Inc. Stock

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:03 2024-04-16 pm EDT 5-day change 1st Jan Change
25.69 USD -0.85% Intraday chart for Pfizer, Inc. -4.07% -10.77%
Sales 2024 * 60.02B Sales 2025 * 62.6B Capitalization 147B
Net income 2024 * 6.92B Net income 2025 * 9.43B EV / Sales 2024 * 3.23 x
Net Debt 2024 * 47.04B Net Debt 2025 * 41.91B EV / Sales 2025 * 3.01 x
P/E ratio 2024 *
16.4 x
P/E ratio 2025 *
13.2 x
Employees 88,000
Yield 2024 *
7.14%
Yield 2025 *
7.45%
Free-Float 59.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.04%
1 week-2.52%
Current month-6.63%
1 month-7.27%
3 months-9.72%
6 months-19.31%
Current year-10.00%
More quotes
1 week
25.75
Extreme 25.75
26.59
1 month
25.75
Extreme 25.75
28.12
Current year
25.61
Extreme 25.61
30.28
1 year
25.61
Extreme 25.61
41.33
3 years
25.61
Extreme 25.61
61.71
5 years
25.61
Extreme 25.61
61.71
10 years
25.61
Extreme 25.61
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-04-16 25.69 -0.85% 28,856,237
24-04-15 25.91 +0.19% 35,660,191
24-04-12 25.86 -1.82% 43,034,056
24-04-11 26.34 +0.08% 32,814,471
24-04-10 26.32 -1.72% 44,541,594

Delayed Quote Nyse, April 15, 2024 at 04:00 pm EDT

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
25.91 USD
Average target price
31.62 USD
Spread / Average Target
+22.04%
Consensus